Search Options Stock News and Analysis from Schaeffer's

Vaccine Staple Gears Up for Earnings Report

https://www.schaeffersresearch.com/content/analysis/2021/07/28/vaccine-staple-trades-flat-ahead-of-earnings

7/28/2021 1:03 PM

The shares of AstraZeneca plc (NYSE:AZN) are down 0.3%, last seen trading at $57.27 as the vaccine staple gets ready to step into the earnings confessional. AstraZeneca is slated to report second-qu...

Benchmarks Gain Momentum to Close Volatile Week

https://www.schaeffersresearch.com/content/news/2021/05/21/benchmarks-gain-momentum-to-close-volatile-week

5/21/2021 2:06 PM

This past week was a rocky one for Wall Street. On Monday, inflation fears persisted from the previous week's Consumer Price Index (CPI) reading, which weighed heavily on Big Tech, and investors co...

Moderna Vaccine Gains Approval in Japan, South Korea

https://www.schaeffersresearch.com/content/news/2021/05/21/moderna-vaccine-gains-approval-in-japan-south-korea

5/21/2021 10:42 AM

Japanese and South Korean regulators officially approved Moderna Inc's (NASDAQ:MRNA) Covid-19 vaccine, alongside the vaccine produced by AstraZeneca (AZN) and Oxford University. Moderna is drumming up...

AZN Adds to Vaccine Buzz on New Study

https://www.schaeffersresearch.com/content/news/2021/05/19/azn-adds-to-vaccine-buzz-on-new-study

5/19/2021 10:14 AM

AstraZeneca PLC (NASDAQ:AZN) is in the spotlight today, after the Financial Times reported that the company's Covid-19 vaccine works well as a third booster shot, according to a study by Oxford Univer...

AstraZeneca Revises Vaccine Efficacy Rate, Stock Inches Higher

https://www.schaeffersresearch.com/content/news/2021/03/25/astrazeneca-revises-vaccine-efficacy-rate-stock-inches-higher

3/25/2021 10:07 AM

The shares of AstraZeneca plc (NASDAQ:AZN) have seen a lot of movement lately, with the drugmaker's Covid-19 vaccine popping up in the news almost daily. Once again, the security is making headlines...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity